On August 15th, Jinshi Data reported that the Anhui Provincial Medical Centralized Procurement Platform announced the latest procurement catalog for the Anhui Province’s 2024 coronavirus vaccine and some non-immunization plan vaccines. Watson Biotechnology’s OmicronXBB.1.5, a new coronavirus variant bead mRNA vaccine, was included in the procurement catalog at a price of 278 yuan per dose. The previous day’s price for this product was 94 yuan per dose, a decrease of about 70% compared to the price announced by Shandong. Watson Biotechnology confirmed that the price announced by Anhui on the previous day was incorrect, and the latest correct price is consistent with the price in Shandong, and there has been no price reduction.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
